SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-20
👔
abrdn Life Sciences Investors
@HQL_InsiderForm 4 Filing: Mahai Chris LaVictoire Buys $10,497.84 of $HQL
INSIDER PURCHASE
⚡ MATERIALITY: 5/10
corporate issuer
abrdn Life Sciences Investors
Ticker: $HQL
Transaction Value
$10,497.84
Price/Share: $19.92
transaction date
2026-07-16
Shares: 527
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mahai Chris LaVictoire, holds the title of Director at abrdn Life Sciences Investors.
On 2026-07-16, the insider transacted 527 shares.The shares were transacted at a weighted average price of $19.92 per share, resulting in a total market-relevant value of $10,497.84.
Executive Summary Summary
Mahai Chris LaVictoire (Director) bought $10K of $HQL
Post-Transaction Position: 527 shares
SEC Accession No: 0001104659-26-085027 (CIK: 1335892)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.